CY2020015I2 - Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα - Google Patents
Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογαInfo
- Publication number
- CY2020015I2 CY2020015I2 CY2020015C CY2020015C CY2020015I2 CY 2020015 I2 CY2020015 I2 CY 2020015I2 CY 2020015 C CY2020015 C CY 2020015C CY 2020015 C CY2020015 C CY 2020015C CY 2020015 I2 CY2020015 I2 CY 2020015I2
- Authority
- CY
- Cyprus
- Prior art keywords
- ciclesonide
- horses
- treatment
- airway disease
- airway
- Prior art date
Links
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 title 1
- 229960003728 ciclesonide Drugs 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12199302 | 2012-12-21 | ||
EP13811924.3A EP2934479B1 (en) | 2012-12-21 | 2013-12-18 | Ciclesonide for the treatment of airway disease in horses |
PCT/EP2013/077265 WO2014096115A1 (en) | 2012-12-21 | 2013-12-18 | Ciclesonide for the treatment of airway disease in horses |
Publications (2)
Publication Number | Publication Date |
---|---|
CY2020015I1 CY2020015I1 (el) | 2020-11-25 |
CY2020015I2 true CY2020015I2 (el) | 2021-03-12 |
Family
ID=47552829
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY181101189T CY1121115T1 (el) | 2012-12-21 | 2018-11-09 | Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα |
CY2020015C CY2020015I2 (el) | 2012-12-21 | 2020-06-29 | Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY181101189T CY1121115T1 (el) | 2012-12-21 | 2018-11-09 | Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα |
Country Status (24)
Country | Link |
---|---|
US (4) | US20140179651A1 (el) |
EP (1) | EP2934479B1 (el) |
AR (1) | AR094241A1 (el) |
AU (2) | AU2013360691B2 (el) |
BR (2) | BR122016029247A2 (el) |
CA (1) | CA2888428C (el) |
CY (2) | CY1121115T1 (el) |
DK (1) | DK2934479T3 (el) |
ES (1) | ES2693779T3 (el) |
FR (1) | FR20C1026I1 (el) |
HR (1) | HRP20181980T1 (el) |
HU (1) | HUS2000020I1 (el) |
IN (1) | IN2015DN02894A (el) |
LT (2) | LT2934479T (el) |
MA (1) | MA38169B2 (el) |
MX (1) | MX368306B (el) |
NO (1) | NO2020014I1 (el) |
NZ (1) | NZ706573A (el) |
PL (1) | PL2934479T3 (el) |
PT (1) | PT2934479T (el) |
RS (1) | RS57740B1 (el) |
SI (1) | SI2934479T1 (el) |
WO (1) | WO2014096115A1 (el) |
ZA (1) | ZA201502288B (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103781468A (zh) | 2011-08-12 | 2014-05-07 | 勃林格殷格翰动物保健有限公司 | 治疗及预防猫科动物心脏衰竭的方法中所用的起搏电流(If)抑制剂 |
LT2934479T (lt) | 2012-12-21 | 2018-12-27 | Boehringer Ingelheim Vetmedica Gmbh | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui |
IN2015DN02999A (el) | 2012-12-21 | 2015-09-25 | Boehringer Ingelheim Vetmed | |
SI3157522T1 (sl) | 2014-06-18 | 2020-01-31 | Boehringer Ingelheim Vetmedica Gmbh | Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih |
WO2018070819A1 (ko) * | 2016-10-14 | 2018-04-19 | 제주대학교 산학협력단 | 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물 |
US20230033224A1 (en) | 2020-01-10 | 2023-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for ameliorating quality of life (qol) in equines |
MX2023001201A (es) | 2020-07-31 | 2023-05-03 | Chemo Res S L | Terapia combinada para la administracion por inhalacion. |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5954049A (en) | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
US6706726B2 (en) | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
DE10237739A1 (de) | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
US20040053902A1 (en) | 2002-09-13 | 2004-03-18 | Smith C. Steven | Novel composition and method for treatment of upper respiratory conditions |
JP2006528228A (ja) | 2003-05-22 | 2006-12-14 | アルタナ ファルマ アクチエンゲゼルシャフト | サルメテロール及びシクレソニドの組合せ物 |
US20050020692A1 (en) | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
EP1670482B2 (en) | 2003-09-16 | 2022-06-29 | Covis Pharma B.V. | Use of ciclesonide for the treatment of respiratory diseases |
PE20050941A1 (es) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
CA2563556C (en) | 2004-04-20 | 2013-01-29 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
JP2008504341A (ja) | 2004-06-29 | 2008-02-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ステロイドと抗コリン作用剤とを含む吸入用薬剤 |
DE102004056579A1 (de) | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid |
UY30543A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
US9084660B2 (en) | 2009-06-25 | 2015-07-21 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
US7829748B1 (en) | 2009-09-21 | 2010-11-09 | Honeywell International Inc. | Process for the manufacture of 1,3,3,3-tetrafluoropropene |
EA201590030A1 (ru) | 2012-07-05 | 2015-09-30 | Арвен Айлак Санайи Ве Тиджарет А.С. | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент |
US20150202148A1 (en) | 2012-07-05 | 2015-07-23 | Arven llac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
US9539408B2 (en) | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
IN2015DN02999A (el) | 2012-12-21 | 2015-09-25 | Boehringer Ingelheim Vetmed | |
LT2934479T (lt) | 2012-12-21 | 2018-12-27 | Boehringer Ingelheim Vetmedica Gmbh | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui |
KR102456231B1 (ko) | 2013-08-20 | 2022-10-20 | 베링거잉겔하임베트메디카게엠베하 | 흡입기 |
NZ714524A (en) | 2013-08-20 | 2020-07-31 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
SI3157522T1 (sl) | 2014-06-18 | 2020-01-31 | Boehringer Ingelheim Vetmedica Gmbh | Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih |
-
2013
- 2013-12-18 LT LTEP13811924.3T patent/LT2934479T/lt unknown
- 2013-12-18 NZ NZ70657313A patent/NZ706573A/en unknown
- 2013-12-18 DK DK13811924.3T patent/DK2934479T3/en active
- 2013-12-18 PL PL13811924T patent/PL2934479T3/pl unknown
- 2013-12-18 US US14/132,580 patent/US20140179651A1/en not_active Abandoned
- 2013-12-18 BR BR122016029247-9A patent/BR122016029247A2/pt not_active Application Discontinuation
- 2013-12-18 PT PT13811924T patent/PT2934479T/pt unknown
- 2013-12-18 SI SI201331266T patent/SI2934479T1/sl unknown
- 2013-12-18 IN IN2894DEN2015 patent/IN2015DN02894A/en unknown
- 2013-12-18 CA CA2888428A patent/CA2888428C/en active Active
- 2013-12-18 ES ES13811924.3T patent/ES2693779T3/es active Active
- 2013-12-18 RS RS20181190A patent/RS57740B1/sr unknown
- 2013-12-18 US US14/654,009 patent/US9918995B2/en active Active
- 2013-12-18 MA MA38169A patent/MA38169B2/fr unknown
- 2013-12-18 EP EP13811924.3A patent/EP2934479B1/en active Active
- 2013-12-18 MX MX2015007947A patent/MX368306B/es active IP Right Grant
- 2013-12-18 WO PCT/EP2013/077265 patent/WO2014096115A1/en active Application Filing
- 2013-12-18 AU AU2013360691A patent/AU2013360691B2/en active Active
- 2013-12-18 BR BR112015010842-3A patent/BR112015010842B1/pt active IP Right Grant
- 2013-12-20 AR ARP130104978A patent/AR094241A1/es not_active Application Discontinuation
-
2015
- 2015-04-07 ZA ZA2015/02288A patent/ZA201502288B/en unknown
-
2016
- 2016-10-13 US US15/292,765 patent/US10258634B2/en active Active
-
2018
- 2018-02-06 US US15/889,307 patent/US10441597B2/en active Active
- 2018-03-07 AU AU2018201642A patent/AU2018201642B2/en active Active
- 2018-11-09 CY CY181101189T patent/CY1121115T1/el unknown
- 2018-11-26 HR HRP20181980TT patent/HRP20181980T1/hr unknown
-
2020
- 2020-06-12 NO NO2020014C patent/NO2020014I1/no unknown
- 2020-06-18 LT LTPA2020511C patent/LTPA2020511I1/lt unknown
- 2020-06-26 FR FR20C1026C patent/FR20C1026I1/fr active Active
- 2020-06-29 CY CY2020015C patent/CY2020015I2/el unknown
- 2020-06-29 HU HUS2000020C patent/HUS2000020I1/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2020510I1 (lt) | Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui | |
IL285843A (en) | Ibrutinib for use in the treatment of chronic graft versus host disease | |
CY2020015I2 (el) | Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα | |
LT3470063T (lt) | Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui | |
HK1200872A1 (en) | Animal models and therapeutic molecules | |
HUE043171T2 (hu) | Neurodegeneratív betegségek kezelésére hasznos 1-arilkarbonil-4-oxi-piperidinvegyületek | |
DK2919796T3 (da) | Brug af akkermansia til behandling af stofskiftesygdomme | |
DK2863990T3 (da) | Medicinsk mikroelektrode | |
IL237592B (en) | Methods of expanding and assessing b cells and using expanded b cells to treat disease | |
EP2935229A4 (en) | Esterification of 2,5-Furan-Dicarboxylic Acid | |
EP2906208A4 (en) | THERAPEUTIC TREATMENT | |
HK1211210A1 (zh) | 治療多發性硬化症的組合療法 | |
EP2913047A4 (en) | SPECIFIC THERAPEUTIC AGENT OF PULMONARY DISEASE | |
EP3794941C0 (en) | ANIMAL MODELS AND THERAPEUTIC MOLECULES | |
DK3335652T3 (da) | Medicinsk fastgørelseselement | |
EP2872120A4 (en) | TARGETED THERAPEUTIC NANOPARTICLES | |
LT3292875T (lt) | Kompozicijos ir būdai, skirti ligų gydymui | |
HUE053561T2 (hu) | Állatõrzõ kerítés és eljárás annak összeszerelésére | |
BR112014009789A2 (pt) | cisteamina no tratamento da doença fibrótica | |
BR112014026557A2 (pt) | fralda descartável. | |
PL2718434T3 (pl) | Kompozycje i sposoby leczenia choroby trzewnej | |
IL227747A0 (en) | Combinations comprising macitentan for the treatment of glioblastoma multiforme | |
BR112014030277A2 (pt) | sistema médico | |
LT2958624T (lt) | Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas | |
EP2931176A4 (en) | Medical sling |